The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cabozantinib in metastatic renal cell carcinoma (mRCC): Real world experience from the UK.
 
Alfonso Gomez de Liano
Honoraria - Roche/Genentech
 
Balaji Venugopal
No Relationships to Disclose
 
Kate Fife
No Relationships to Disclose
 
Luma Khasti
No Relationships to Disclose
 
Stefan N. Symeonides
Consulting or Advisory Role - Agalimmune (Inst); OCTIMET (Inst)
Research Funding - Merck Sharp & Dohme (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Ipsen
 
Claire Pettinger
No Relationships to Disclose
 
Thomas Powles
Honoraria - Bristol-Myers Squibb; MERCK; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Merck; Novartis
Research Funding - AstraZeneca/MedImmune; Roche/Genentech
Other Relationship - Bristol-Myers Squibb; Ipsen
 
Sarah Maria Rudman
No Relationships to Disclose
 
Naveen Vasudev
No Relationships to Disclose
 
Ekaterini Boleti
No Relationships to Disclose